Titre du document / Document title

Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy

Auteur(s) / Author(s)

JACOB Peyton III ⁽¹⁾ ; HATSUKAMI Dorothy ⁽²⁾ ; SEVERSON Herbert ⁽²⁾ ; HALL Sharon ⁽³⁾ ; YU Lisa ⁽¹⁾ ; BENOWITZ Neal L. ⁽¹⁾ ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Division of Clinical Pharmacology, San Francisco General Hospital Medical Center, Department of Medicine [P. J., L. Y., N. L. B.], Drug Dependence Research Center [P. J.], and Department of Psychiatry [S. H.], University of California, San Francisco, San Francisco, California 94110, ETATS-UNIS
⁽²⁾ Pacific Research Institute, Eugene, Oregon 97403, ETATS-UNIS
⁽³⁾ Department of Psychiatry, University of Minnesota, Minneapolis, Minnesota 55414, ETATS-UNIS

Résumé / Abstract

In this study we determined urine concentration of the tobacco alkaloids anabasine and anatabine, nicotine and its metabolites cotinine, and nornicotine in 99 cigarette smokers and 205 smokeless tobacco users. We also investigated the possibility that anabasine and anatabine can be used as biomarkers for tobacco use during nicotine replacement therapy. Urine samples and data on self-reported tobacco use were obtained from subjects enrolled in tobacco cessation programs. Urine concentrations of tobacco alkaloids and metabolites were measured and correlated with self-reported tobacco use. Concentrations of anabasine and anatabine were used to validate abstinence in smokeless tobacco users who used nicotine gum as part of the therapy. Correlations of alkaloid concentration with self-reported tobacco use before treatment ranged from fair to poor. In subjects abstaining from smokeless tobacco but using nicotine gum, anabasine and anatabine levels were below the cut-point of 2 ng/ml despite high concentrations of nicotine and cotinine resulting from nicotine gum use. Anabasine and anatabine concentrations in urine can be used to validate abstinence or measure the extent of tobacco use in persons undergoing nicotine replacement therapy.

Revue / Journal Title

Cancer epidemiology, biomarkers & prevention   ISSN 1055-9965   CODEN CEBPE4 

Source / Source

2002, vol. 11, n^o12, pp. 1668-1673 [6 page(s) (article)] (29 ref.)

Langue / Language

Anglais

Editeur / Publisher

American Association for Cancer Research, Philadelphia, PA, ETATS-UNIS  (1991) (Revue)

Mots-clés anglais / English Keywords

Abstinence ; Tobacco ; Alkaloid ; Anabasine ; Urine ; Replacement therapy ; Poison withdrawal ; Biological marker ; Toxicity ; Human ; Tobacco smoking ;

Mots-clés français / French Keywords

Anatabine ; Abstinence ; Tabac ; Alcaloïde ; Anabasine ; Urine ; Traitement substitutif ; Sevrage toxique ; Marqueur biologique ; Toxicité ; Homme ; Tabagisme ;

Mots-clés espagnols / Spanish Keywords

Abstinencia ; Tabaco ; Alcaloide ; Anabasine ; Orina ; Tratamiento sustitutivo ; Destete tóxico ; Marcador biológico ; Toxicidad ; Hombre ; Tabaquismo ;

Localisation / Location

INIST-CNRS, Cote INIST : 26637, 35400010364892.0200